Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Site-level cutaneous phenotyping framework for anti-MDA5-positive dermatomyositis: exploratory associations with systemic immune reference markers.

Arthritis research & therapy - 6 Jun 2026

Tian Ziyuan, Bi Lingbo, Han Jiahui, Xue Ke, Cui Yong

Abstract excerpt

OBJECTIVES: To propose and evaluate a CDASI-informed, medical-record-based site-by-lesion cutaneous phenotyping framework for anti-MDA5-positive dermatomyositis, using established systemic and immunological markers as reference anchors to examine whether this framework provides additional phenotypic resolution beyond conventional binary skin assessment. METHODS: This single-centre retrospective cross-sectional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Autoantibodies
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Dermatomyositis

Share to Interferon-Induced Helicase, IFIH1

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 42249434
DOI: 10.1186/s13075-026-03834-6
PMCID: PMC13471506

Genes

PAH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Site-level cutaneous phenotyping framework for anti-MDA5-positive dermatomyositis: exploratory associations with systemic immune reference markers.PMID 42249434Read ↗

A new proposal for phenotypic classification and outcome assessment of dermatomyositis based on clinical manifestations and serological testing.Semantic proximity Read ↗

From machine learning to clinical practice: phenotypic clusters of anti-MDA5 antibody-positive dermatomyositis.Semantic proximity Read ↗

Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease.Semantic proximity Read ↗

Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity Read ↗

Single-cell landscape of peripheral immune response in patients with anti-melanoma differentiation–associated gene 5 dermatomyositisSemantic proximity Read ↗

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.Semantic proximity Read ↗

Multi-Omics Molecular Profiling Enables Rapid Diagnosis of Erythrodermic Skin DiseasesSemantic proximity Read ↗

Correlation between lung microecology and immunity in patients with anti-MDA5 antibody-positive dermatomyositis combined with interstitial lung disease: protocol for a prospective, multicentre cohort studySemantic proximity Read ↗

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.Semantic proximity Read ↗

Anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody dermatomyositis: Clinical features and outcomes in a racially diverse patient cohortSemantic proximity Read ↗

Analysis of the Potential Link Between Dermatomyositis and CancerSemantic proximity Read ↗

Integrated multi-dimensional analyses reveal a BTN3A2-centered diagnostic risk score and a monocyte-T cell axis as central drivers of dermatomyositis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.